Chronic Diabetic Foot Ulcers Clinical Trial
Official title:
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Phase-III Study to Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
The primary efficacy endpoint for this study is the proportion of subjects with complete closure of Target Ulcer during the 20-week Treatment Phase, which is assessed by the blinded independent evaluator.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04457752 -
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
|
Phase 4 | |
Terminated |
NCT02571738 -
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
|
Phase 3 | |
Completed |
NCT00632008 -
Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers
|
Phase 3 | |
Recruiting |
NCT00366132 -
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers
|
Phase 2 | |
Terminated |
NCT05276401 -
Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
|
Phase 2 | |
Completed |
NCT03282981 -
Beta Adrenergic Antagonist for the Healing of Chronic DFU
|
Phase 3 | |
Completed |
NCT02098447 -
Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds
|
N/A | |
Withdrawn |
NCT00954343 -
Shockwave Treatment of Diabetic Foot Ulcer: Step I
|
N/A |